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Abstract
Background: Sulfotransferases are a large group of enzymes that regulate the biological activity or availability of a
wide spectrum of substrates through sulfation with the sulfur donor 3’-phosphoadenosine-5’-phosphosulfate
(PAPS). These enzymes are known to be difficult to assay. A convenient assay is needed in order to better
understand these enzymes.
Results: A universal sulfotransferase assay method based on sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) is described. This assay has been successfully applied to substrates as small as a-
naphthol and as big as proteoglycans. As examples, we present the assays for recombinant human CHST4, TPST1,
CHST3 and HS6ST1. In order to assess whether a small molecule can be applicable to this type of assay, a method
to estimate the relative mobility of a molecule to PAPS is also presented. The estimated relative mobilities of
various sulfated small molecules generated by SULT1A1, SULT1E1, SULT2A1 and CHST4 are in the range of ± 0.2 of
the actual relative mobilities.
Conclusion: The versatility of the current method comes from the ability that SDS-PAGE can separate proteins and
small molecules according to different parameters. While mobilities of proteins during SDS-PAGE are inversely
related to their sizes, mobilities of small molecules are positively related to their charge/mass ratios. The predicted
relative mobility of a product to PAPS is a good indicator of whether a sulfotransferase can be assayed with SDS-
PAGE. Because phosphorylation is most similar to sulfation in chemistry, the method is likely to be applicable to
kinases as well.
Background
Sulfation is a ubiquitous post-translational modification
that affects the biological activity of a wide variety of
substrates, ranging in molecular mass from less than 10
3
to greater than 10
6 Da. The reaction is catalyzed by sul-
fotransferases using 3’-phosphoadenosine-5’-phosphosul-
fate (PAPS)
1 as the sulfate donor [1]. There are 48
sulfotransferases in humans and they can be divided
into two major groups according to their sub-cellular
localization: those found in cytoplasm and those found
in the Golgi apparatus [2]. Cytosolic sulfotransferases,
commonly designated as SULTs, are mainly involved in
modifying small molecules (in general < 1000 Da in
mass), such as steroids, neurotransmitters, and xenobio-
tics [3]. Along with P450 enzymes, SULTs play impor-
tant roles in drug detoxification [4,5]. Golgi resident
sulfotransferases are involved in modifying numerous
glycans and proteins on the cell membranes and within
extracellular matrix. Glycan sulfation is known to affect
hormone pharmacokinetics [6], growth factor and
cytokine activity [7], viral [8] and bacterial [9] invasion.
Protein sulfation is known to be important in protein-
protein interactions, such as leukocyte adhesion
molecule PSGL-1 binding to P-selectin on activated
endothelium [10,11].
Although the significance and pervasiveness of sulfa-
tion have gradually been realized, research on this area
has been hampered by the inconvenient assay systems
currently available. Usually, sulfotransferase assays rely
on chromatography steps, such as HPLC [12-14] and
TLC [15-17], to separate substrates and products. How-
ever, HPLC is difficult to process multiple samples and
TLC is unsuitable to separate proteins and polysacchar-
ides. Recently, HPLC coupled mass spectrometry has
been applied to characterize sulfotransferase products
[18,19], but it is difficult to assess enzymatic activity due * Correspondence: leon.wu@rndsystems.com
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and fluorescent sulfotransferase assays [21] have also
been explored, but these assays are limited to substrates
with colorimetric or fluorescent properties. We have
developed a versatile electrophoresis-based sulfotransfer-
ase assay that can be applied to substrates ranging from
small molecules, such as a-naphthol, to large molecules,
such as proteoglycans, by taking advantage of the fact
that both small and large molecules can be separated
from PAPS during SDS-PAGE (Figure 1).
Results
Assay development for rhCHST4
As an illustration of the general procedure of assay
development for all sulfotransferases, the assay for
recombinant human carbohydrate sulfotransferase 4
(rhCHST4) is described here (Figure 2). CHST4, also
known as high endothelial cell N-acetylglucosamine 6-
O-sulfotransferase (HEC-GlcNAc6ST) or L-selectin
ligand sulfotransferase (LSST), catalyzes the sulfation
at the 6-O position of the non-reducing end N-acetyl-
glucosamine (GlcNAc) residues within mucin-asso-
ciated glycans [22]. Instead of using native glycan, we
used a disaccharide GlcNAcMan as the acceptor
substrate.
Each rhCHST4 reaction started with 2,500 pmol
acceptor substrate and 1,000 pmol of donor substrate.
To locate the linear response region of rhCHST4, an
activity-enzyme plot was first established from 0 to
500 ng enzyme input in a 2-fold serial dilution fashion
(Figure 2A, Additional file 1, Table S1). The linear
response region was then located from 0 to 40 ng of
enzyme input and the experiment was repeated within
this region. A second activity-enzyme plot was then
established and a linear regression equation was
obtained based on this second plot (Figure 2B,
Additional file 1, Table S2). Because the equation was
based on four consecutive data points and had correla-
tion coefficient R
2 = 0.990, the slope of the equation,
391 pmol/min/μg, was then accepted as the measured
specific activity of rhCHST4.
To make sure that rhCHST4 was stable over the time,
a product-time plot was also conducted (Figure 2C,
Additional file 1, Table S3). In this experiment, the
amount of enzyme was fixed at 7.5 ng, but reaction time
varied from 0 to 20 minutes. The enzyme showed a
good linear product-time course (correlation coefficient
R
2 = 0.993), indicating that the enzyme was stable over
the time. This result therefore validated the 20 minute
reaction time used in previous experiments.
Assay Examples
SDS-PAGE based sulfotransferase assay has been suc-
cessfully applied to all sulfotransferases that are available
to us thus far. To further illustrate the versatility of this
method, we describe the assays of several other repre-
sentative sulfotransferases using different acceptor sub-
strates. To avoid redundancy, only data directly showing
specific activity are presented here (Figure 3).
TPST1 assay using PSGL-1 peptide as the acceptor
Tyrosylprotein sulfotransferase (TPST) transfers sulfates
to the P-selectin glycoprotein ligand-1 (PSGL-1) on
myeloid cells and stimulated T lymphocytes and plays a
critical role in the tethering of these cells to activated
platelets or endothelia that express P-selectin [23].
Recombinant human TPST1 (rhTPST1) was assayed
using 25,000 pmol of acceptor substrate PSGL-1 peptide
and 1,000 pmol of PAPS in at 37°C for 20 minutes.
Enzyme linear response region was located from 0 to
500 ng of enzyme input. Under these conditions, the
specific activity was determined to be 22.6 pmol/min/μg
(Figure 3A).
Product
PAPS
35S
process
SO4 -2
Figure 1 Scheme of electrophoresis based sulfotransferase assay. The assay mainly consists of four steps. First, spike sulfotransferase
reaction with PAP
35S. Second, separate the reactions on 8% SDS gel by electrophoresis and obtain an autoradiogram of the dried gel.
Generation of the free sulfate is inevitable due to the degradation of PAPS. Third, cut out the hot spots on the dried gel and count the
radioactivity. Fourth, data process.
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Carbohydrate sulfotransferases 3 (CHST3), also known
as chondroitin 6-sulfotransferase, catalyzes the sulfation
at the 6-O position of the N-acetylgalactosamine
(GalNAc) residues on chondroitin sulfate [24]. In this
example, assay was done using 5,000 pmol of PAPS and
100 μg of bovine chondroitin sulfate as the acceptor
substrate. Other assay conditions were the same as
those of rhCHST4. Under these conditions, recombinant
human CHST3 (rhCHST3) showed a specific activity of
248 pmol/min/μg (Figure 3B).
HS6ST3 assay using recombinant human syndecan-4
as the acceptor
Heparan sulfate 6-O sulfotransferase 3 (HS6ST3) trans-
fers sulfate to the 6-O position of GlcNAc residues on
heparan sulfate [25]. To assay HS6ST3, recombinant
human syndecan 4, a known heparan sulfate proteogly-
can, was used as the acceptor substrate. Each reaction
was conducted with 10 μg of acceptor substrate and
1,000 pmol of PAPS in the presence of 0.3 mg/mL pro-
tamine. Other assay conditions were the same as those
of rhCHST4. Under these conditions, recombinant
human HS6ST3 (rhHS6ST3) showed a specific activity
of 14 pmol/min/μg (Figure 3C). This experiment also
proved that the recombinant syndecans 4 carried func-
tional heparan sulfate.
Relative Mobility of a Small Molecule to PAPS
It is clear that the ability of SDS-PAGE to separate both
large molecules, such as recombinant syndecans 4, and
small molecules, such as PAPS, is essential to the cur-
rent assay systems. While it is known that protein
separation in SDS-PAGE is mainly due to differences in
molecular size, the separation of small molecules during
electrophoresis is not well studied. To see whether a
small molecule can be separated from PAPS and be
applicable to the current assay method, we defined ideal
mobility (M)a st h es p e e dt h a tt h es m a l lm o l e c u l et r a -
vels in a constant electric field without any resistance.
According to this definition, the following equation was
derived (Additional file 2),
ME t
q
m

1
2
(1)
q, charge; m, mass; E, electric field strength; t, running
time.
Eq.1 indicates that the mobility of a small molecule
under ideal conditions is dependent on electric field
strength, running time, and, q/m ratio. For all molecules
in a same electrophoresis, electric field strength and
running time are always the same, but the q/m ratios
a r eu n i q u et ot h em o l e c u l e s .I no r d e rt oh a v eam o r e
Figure 2 Assay development for rhCHST4. The enzyme was assayed with the acceptor substrate of a disaccharide GlcNAcMan. A) Activity-
enzyme plot and the linear response region. The reactions were performed with fixed substrate inputs (2,500 pmol GlcNAcMan and 1,000 pmol
of PAPS) but varied enzyme input from 0 to 500 ng. The calculated activity was then plotted against the enzyme inputs. The linear response
region was located from 0 to 40 ng of enzyme input. Last lane contained no acceptor substrate. B) The experiment was repeated in the linear
region. A linear least-square line was fitted to the activity-enzyme plot and the slope of the line was the specific activity for rhCHST4. The
second lane contained no acceptor substrate. C) A product-time course of rhCHST4. All reactions contained 7.5 ng enzymes but reaction time
varied from 0 to 20 minutes. The relative mobilities of the product and PAPS were slightly different due to variations on the electrophoresis
buffer preparation. The faint spots right above the PAPS were likely due to APS, a PAPS degradation product, which was observed especially
with aged PAPS preparation.
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defined relative mobility (M’) of a small molecule as the
ratio of its mobility to that of PAPS (Mp).
M
M
Mp
qm
qp mp
’  (2)
Since the charge and mass of PAPS (qp and mp
respectively) under defined conditions are constant, M’
of a small molecule is only dependent on its own q/m
ratio. The value of M’ suggests whether the molecule
can be separated from PAPS during electrophoresis. The
estimated relative mobilities of some small molecules
encountered in this report are listed in Table 1. Because
most of the sulfated small molecules have estimated
relative mobilities less than 1, meaning that they move
slower than PAPS in an electrophoresis, these molecules
are likely to be applicable to SDS-PAGE based sulfo-
transferase assay.
Estimated Relative Mobility Correlated Well with
Observed Mobility
To see how the estimated relative mobilities correlate to
the actual relative mobilities for the small molecules
listed in Table 1 and further prove that this electrophor-
esis based assay can be applied to these small molecules,
we sulfated corresponding small molecule substrates
using SULT1A1, SULT1E1, SULT2A1 and CHST4, and
then separated the reactions on an 8% SDS gel (Figure
4). Except the reaction for SULT1A1/dopamine where
two products were observed, one product resulted in
other reactions.
According to the definition of mobility, the relative
mobility of a small molecule should also be equal to the
ratio of the distance that it travels (L) and the distance
that PAPS travels (Lp), i.e.
M
M
Mp
Lt
Lp t
L
Lp
’   (3)
The distances of the products and PAPS traveled in
Figure 4 were then measured and the observed relative
mobilities of these products were obtained (Table 1).
The observed values were in the range of ± 0.2 of the
estimated values.
The slow and fast moving bands in the SULT1A1/
dopamine reaction (lane 2, Figure 4) are likely due to
mono- and di-sulfated dopamine respectively, because
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Figure 3 Examples showing the versatility of the sulfotransferase assay. A) rhTPST1 assay using PSGL-1 peptide as the acceptor. B)
rhCHST3 assay using chondroitin sulfate as the acceptor. C) rhHS6ST3 assay using recombinant human syndecan-4 as the acceptor. See text for
experimental conditions.
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Page 4 of 9Table 1 Estimated and observed relative mobilities of some of the small molecules that were encountered in this
report.
Molecules
a Charges
b on -SO3
- Other Charges
b q m q/m × 1000 Estimated Relative
mobility (M’)
Observed relative
mobility
Dopamine-1S -1 +1
c 0 234.2 0.00 0.00 0.05
GlcNAc-Man-1S -1 0 -1 477.4 -2.09 0.35 0.35
Estradiol-1S -1 0 -1 352.4 -2.84 0.48 0.37
DHEA-1S -1 0 -1 367.5 -2.72 0.46 0.45
Lithocholic acid-1S -1 -1 -2 455.6 -4.39 0.74 0.63
Dopamine-2S -2 0 ~ +1
d -2 ~ -1 312.2/313.2 -3.19 ~ -6.39 0.54 ~ 1.07 0.72
a-Naphthol-1S -1 0 -1 224.2 -4.46 0.75 0.80
p-nitrophenol-1S -1 0 -1 218.1 -4.59 0.77 0.96
APS -1 -1 -2 425.28 -4.70 0.79 0.96
PAPS -1 -2 -3
e 504.3 -5.95 1.00 1.00
Bromophenol blue
f -2 -2 668 -2.99 0.50 0.63
Free sulfate -2 -2 96 -20.83 3.5 1.24
aNumbers of sulfate groups are indicated as -nS.
bThe charge numbers on the molecules were estimated based on the numbers of their charged groups, such as -COO
-,- N H 3
+ and -SO3
-. Because some functional
groups were partially charged due to the influence of other neighboring functional groups, the corresponding charge number and relative mobility were only
estimation.
cAssuming the -NH3
+ on mono-sulfated dopamine (estimated pKa = 9.5) is completely protonated at pH 8.0.
dAssuming the amine group on the di-sulfated dopamine can only partially protonated, because the two negatively charged sulfate groups could shift the pKa of
the -NH3
+ closer to 8.0.
e Fully charged PAPS would have a charge number of -4; however, under the assay conditions, PAPS could be partially charged and the charge number -3 was
assumed here. The most similar molecule, ATP, can exist in MgATP
2-,A T P
4- and ATP
3- species [34] and overall charge number could be close to -3 too.
fBromophenol blue has about half of the mobility of PAPS and is used as an indicator during electrophoresis.
Figure 4 Relative mobility of various sulfated small molecule products. To maximize the sensitivity of the detection, no cold PAPS was
added into these reactions. Acceptor substrates are indicated on top of the autoradiogram. Lane 1 contained no acceptor substrate but 1 μgo f
rhSULT1A1. Lane 2, 3, 4 were labeled with 1 μg of rhSULT1A1, rhSULT1E1 and rhCHST4 respectively. All other lanes were labeled with 1 μg
rhSULT2A1. Two product bands were observed in rhSULT1A1/dopamine reaction (lane 2) but not in rhSULT1E1/dopamine reaction (lane 3).
Acceptor substrate inputs from lane 2 to 9 respectively were: 100 nmol dopamine, 100 nmol dopamine, 20 nmol GlcNAcMan, 10 nmol estradiol,
1 nmol DHEA, 10 nmol lithocholic acid, 10 nmol a-naphthol, and 100 nmol p-nitrophenol. The broken line indicates the position of the sulfated
lithocholic acid. The distances that sulfated lithocholic acid and PAPS traveled are indicated as Lc and Lp, respectively. The ratio of Lc and Lp, 0.63,
is the observed relative mobility for mono-sulfated lithocholic acid.
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estimated relative mobilities for mono- and di-sulfated
dopamine respectively. While PAPS was almost comple-
tely consumed in some reactions (lane 4 and 6, Figure
4), significant amount of PAPS remained in other reac-
tions (lane 3, 5, 8, Figure 4). In each reaction, PAPS was
consumed by enzymatic sulfation, the rate of which was
determined by enzyme kinetics, as well as degradation,
which was evidenced by the presence of free sulfate in
each reaction. It was to our advantage to leave some
PAPS unconsumed so that we could determine the rela-
tive mobilities of the products.
Discussion
We have developed a sulfotransferase assay in which
the separation of sulfated products and donor substrate
PAPS is achieved using electrophoresis. In each sulfo-
transferase assay, an activity-enzyme plot was first
obtained to locate the linear response region; a second
experiment was then performed within this linear
region. The specific activity of the enzyme was the
slope of the linear regression equation that was
obtained upon the second activity-enzyme plot. Nor-
mally, the linear response region was within low per-
centage of PAPS consumption (<30%) to avoid the
buildup of the side products including 3’-phosphoade-
nosine-5’-phosphate (PAP) and adenosine-5’-phospho-
sulfate (APS). PAP is reported to be a potent inhibitor
to several sulfotransferases [26]. The affect of APS to
the assay is less clear and the buildup of APS was only
seen in aged PAPS preparation. Because sulfotransfer-
ase activities are also highly dependent on substrate
concentrations due to normal enzyme kinetics and sub-
strate inhibitions that are unique to some of the sulfo-
transferases [3,27], all initial substrate inputs were
specified in each assay.
This electrophoresis based sulfotransferase assay can
be applied to substrates as small as a-naphthol and as
large as recombinant proteoglycans. This versatility
comes from that SDS-PAGE can separate large
proteins and small molecules based on different
parameters. Separation of proteins, including proteo-
glycans, is largely based on size. Separation of small
molecules is largely based on q/m ratio. For cases
where small molecules are used as acceptor substrates,
the estimated relative mobility of a sulfated product to
PAPS can be used to predict whether the molecule is
suitable for electrophoresis-based sulfotransferase
assay.
The estimated relative mobility correlated better with
the observed values for molecules with defined charge
numbers, such as DHEA-1S and GlcNAc-Man-1S, than
the molecules with uncertain charge numbers, such as
dopamine-2S and lithocholic acid-1S (Table 1). This
uncertainty was because of the unknown protonation
states of some functional groups that were influenced by
neighboring functional groups. A much larger deviation
of the estimated relative mobility from the observed
relative mobility was observed for free sulfate, which
may be due to much stronger counter-ion interaction
during electrophoresis.
Although the current method was developed based on
assaying various purified recombinant sulfotransferases,
it could be applied to assaying enzyme mixture that
contains multiple sulfotransferases, as long as the
enzymes are specific for different substrates. For exam-
ple, if an extract contains both HS6ST1 and Gal-
NAc4S6S, we can first assay HS6ST1 activity with
heparan sulfate as the acceptor, and then assay Gal-
NAc4S6S activity with chondroitin sulfate A as the
acceptor. In general, when a certain type of glycosami-
noglycan is used as acceptor, the position of the intro-
duced sulfate is determined by the specificity of the
s u l f o t r a n s f e r a s e .H o w e v e r ,i ti sh a r dt od e t e r m i n et h e
exact sugar residues on a glycosaminoglycan chain that
the sulfate is introduced into. To do that, we need more
sophisticate methods, such as stable isotope labeling
with mass spectrometry analysis [28].
The current electrophoresis-based assay offers sev-
eral advantages. First, this method allows processing
multiple samples simultaneously; therefore it is amen-
able to inhibitor screening and drug development.
Although the current format using standard polyacry-
lamide gel electrophoresis a p p a r a t u si sk i n do fc u m -
bersome, it is possible to miniaturize the systems by
taking advantage of scientific advances, such as nano-
technology, and to make the system high-throughput
in a similar way that DNA sequencing technology was
transformed from polyacrylamide gel electrophoresis
based method. Second, it easily separates mono-sul-
fated and di-sulfated small molecule products, as sug-
gested in the reaction with dopamine and SULT1A1.
Although mono-sulfated dopamine with sulfation at
either 3-O or 4-O position was reported previously
[29], di-sulfated dopamine containing both 3-O and 4-
O sulfates has not been reported, probably due to the
difficult on separating the two species using traditional
methods. The observation of di-sulfated dopamine
demonstrates how flexible the substrate binding site of
SULT1A1 is [30]. Third, the electrophoresis-based
assay is so versatile that it has been successfully
applied to all kinds of substrates that have been tested
so far. These substrates include proteoglycans, glyco-
saminoglycans, oligosaccharides and various phenolic
small molecules. Finally, because sulfation is biochemi-
cally most similar to phosphorylation, it can be rea-
sonably assumed that this method is applicable to
kinase assay as well.
Wu et al. BMC Biotechnology 2010, 10:11
http://www.biomedcentral.com/1472-6750/10/11
Page 6 of 9Conclusions
We have demonstrated the versatility of PAGE-based
sulfotransferase assay with several representative
enzymes, which include carbohydrate and tyrosylprotein
specific sulfotransferases. Small molecule specific sulfo-
transferases such as SULT1A1 can be assayed as long as
the sulfated product has different mobility than the
donor substrate PAPS. A method for predicting whether
a sulfotransferase can be assayed with the current
method has also been provided.
Methods
PAP
35S was synthesized from carrier free Na2
35SO4 (43
Ci/mg, from American Radiolabeled Chemicals, Inc.),
A T Pa n dp h o s p h o e n o lp y r u v a t eu s i n gA T Ps u l f u r y l a s e ,
inorganic pyrophosphatase, pyruvate kinase and APS
kinase, and purified as previously described [31,32]. APS
kinase (EC 2.7.1.25) was a gift from Dr. Andrew J. Fisher
(University of California-Davis). ATP sulfurylase and
inorganic pyrophosphatase were from New England Bio-
labs. Chondroitin Sulfate, GlcNAcb1-6Mana1-OMe
(GlcNAcMan), heparan sulfate, dopamine, estradiol,
DHEA, lithocholic acid, a-naphthol, p-nitrophenol,
phosphoenol pyruvate and pyruvate kinase were from
Sigma-Aldrich. Recombinant syndecan-4 was from R&D
Systems. PSGL-1 peptide (QATEYEYLDYDFLPET) was
synthesized according to NCBI accession number
NP_002997. Cold PAPS was purchased from EMD Bios-
ciences (Cat. No. 118410).
All sulfotransferases were expressed as N-terminal 6×
His tagged recombinant proteins. For Golgi resident sul-
fotransferases, only the luminal enzymatic domains were
expressed in CHO cells as secreted forms. For cytosolic
sulfotransferases, whole protein sequences were
expressed in E. coli. The recombinant enzymes were
first purified with Ni-affinity resin and then Superdex™
gel filtration or ion-exchange columns (GE Healthcare).
Protein concentrations were quantified with Bradford
assay [33].
In a typical sulfotransferase reaction, a specified
amount of cold PAPS (normally = 1000 pmol), spiked
with >10
6 CPM of PAP
35S (< 0.1 picomol), was mixed
with specified amounts of acceptor substrate and
enzyme in an assay buffer that contained 25 mM MES,
0.5% (w/v) Triton®-X 100, 2.5 mM MgCl2,2 . 5m M
MnCl2, 1.25 mM CaCl2, and 0.75 mg/ml BSA at pH 7.0
(1× assay buffer) in a final volume of 30 μL. The reac-
tion was then incubated at 37°C for 20 minutes and
stopped with 6× SDS stop/loading buffer (100 mM Tris,
10% SDS, 30% glycerol, 60 mM b-mercaptoethanol, and
0.01% bromophenol blue, pH 8.0). The 20-minute reac-
tion time was adopted for all sulfotransferase assays,
because most enzymes were found reasonably stable
over this period of time at the specified reaction condi-
tions. The reaction was then loaded onto a vertical 8%
SDS polyacrylamide gel (Gel buffer: 1.5 M Tris at pH
8.0 with 0.4% SDS). The gel was then subjected to elec-
trophoresis at a constant voltage of 200 volts (~10 v/
cm) with a running buffer (50 mM Tris at pH 8.0) for
25 minutes or till the dye (bromophenol blue) was half
way to the bottom of the gel. Under these conditions,
PAPS would be retained on the gel.
The gel was then transferred onto a cellulose chroma-
tography paper (Fisher Scientific, Cat# 05714-1) and
dried in a gel dryer at 80°C under vacuum. The dried
gel was tagged with two Glogos® II autorad markers
(Stratagene, Catalog # 420202) and exposed to X-ray
film for a minimum of two hours. After the film was
developed, the positions of the product and PAP
35S
were identified by overlaying the autoradiogram and gel
using the markers for alignment. The hot spots were
then cut out and counted with a LS 6500 scintillation
counter in Ready Safe™ cocktail (Beckman Coulter). The
activity of each reaction was calculated with the follow-
ing equation,
Activity S C C t it   // , 1 (4)
S donor substrate input; Ci incorporated counts; Ct
total counts including incorporated and unincorporated;
t reaction time. Because the actual contribution from
PAP
35S was negligible, the donor input S was calculated
only based on cold PAPS.
For specific activity determination, an activity-enzyme
response plot (activity against enzyme input) was first
established based on multiple reactions that covered a
wide range of enzyme inputs to locate the linear
response region. A second activity-enzyme response plot
was then repeated only within this linear response
region. The slope of the linear regression equation of
this second activity-enzyme plot was then taken as the
measured specific activity of the enzyme. For accuracy,
the specific activity was considered to be acceptable,
only if the equation was based on at least three consecu-
tive points in a two-fold series dilution fashion and had
the linear regression coefficient R
2 > 0.96.
Additional file 1: Data calculation for Figure 2. This file contains the
raw data and activity calculation for Figure 2. The raw data include the
enzyme input and the radio isotope counts for the product and free
PAPS in each reaction. Activity calculation was based on the equation
Activity = S·Ci/Ct·1/t, (Eq.4). Ci, incorporated counts found in product;
Cpaps, counts of free PAPS; Ct, total counts; S, donor substrate input; t,
time. The calculated activities were then plotted out against the enzyme
inputs in Figure 2.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-6750-10-
11-S1.DOC]
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Page 7 of 9Additional file 2: Induction of Equation 1. This file describes how the
equation for ideal mobility of a charged small molecule,
ME t
q
m  1
2
, was obtained.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-6750-10-
11-S2.DOC]
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